Vascular Surgery Flashcards
Peripheral arterial disease
Peripheral arterial disease (PAD) refers to the narrowing of the arteries supplying the limbs and periphery, reducing the blood supply to these areas. It usually refers to the lower limbs, resulting in symptoms of claudication.
Intermittent claudication
Intermittent claudication is a symptom of ischaemia in a limb, occurring during exertion and relieved by rest. It is typically a crampy, achy pain in the calf, thigh or buttock muscles associated with muscle fatigue when walking beyond a certain intensity.
Critical limb ischaemia
Critical limb ischaemia is the end-stage of peripheral arterial disease, where there is an inadequate supply of blood to a limb to allow it to function normally at rest. There is a significant risk of losing the limb.. The features are pain at rest, non-healing ulcers and gangrene. Pain is worse at night when the leg is raised, as gravity no longer helps pull blood into the foot.
Acute limb ischaemia
Acute limb ischaemia refers to a rapid onset of ischaemia in a limb. Typically, this is due to a thrombus (clot) blocking the arterial supply of a distal limb, similar to a thrombus blocking a coronary artery in myocardial infarction.
Atherosclerosis
Athero- refers to soft or porridge-like and -sclerosis refers to hardening. Atherosclerosis is a combination of atheromas (fatty deposits in the artery walls) and sclerosis (the process of hardening or stiffening of the blood vessel walls). Atherosclerosis affects the medium and large arteries. It is caused by chronic inflammation and activation of the immune system in the artery wall. Lipids are deposited in the artery wall, followed by the development of fibrous atheromatous plaques.
These plaques cause:
Stiffening of the artery walls, leading to hypertension (raised blood pressure) and strain on the heart (whilst trying to pump blood against increased resistance)
Stenosis, leading to reduced blood flow (e.g., in angina)
Plaque rupture, resulting in a thrombus that can block a distal vessel and cause ischaemia (e.g., in acute coronary syndrome)
Atherosclerosis risk factors
It is important to break these down into modifiable and non-modifiable risk factors. We can do nothing about non-modifiable risk factors, but we can do something about modifiable ones.
Non-modifiable risk factors:
Older age
Family history
Male
Modifiable risk factors:
Smoking
Alcohol consumption
Poor diet (high in sugar and trans-fat and low in fruit, vegetables and omega 3s)
Low exercise / sedentary lifestyle
Obesity
Poor sleep
Stress
Medical co-morbidities and atherosclerosis
Medical co-morbidities increase the risk of atherosclerosis and should be carefully managed to minimise the risk:
Diabetes
Hypertension
Chronic kidney disease
Inflammatory conditions such as rheumatoid arthritis
Atypical antipsychotic medications
TOM TIP: Think about risk factors when taking a history from someone with suspected atherosclerotic disease (such as someone presenting with intermittent claudication). Ask about their exercise, diet, past medical history, family history, occupation, smoking, alcohol intake and medications. This will help you perform well in exams and when presenting to seniors.
End results of atherosclerosis
Angina
Myocardial infarction
Transient ischaemic attack
Stroke
Peripheral arterial disease
Chronic mesenteric ischaemia
Intermittent claudication
Peripheral arterial disease presents with intermittent claudication. Patients describe a crampy pain that predictably occurs after walking a certain distance. After stopping and resting, the pain will disappear. The most common location is the calf muscles, but it can also affect the thighs and buttocks.
Acute limb ischaemia
The features of acute limb ischaemia can be remembered with the “6 P’s” mnemonic:
Pain
Pallor
Pulseless
Paralysis
Paraesthesia (abnormal sensation or “pins and needles”)
Perishing cold
Leriche syndrome
Leriche syndrome occurs with occlusion in the distal aorta or proximal common iliac artery. There is a clinical triad of:
Thigh/buttock claudication
Absent femoral pulses
Male impotence
Examining peripheral arterial disease
Look for risk factors:
Tar staining on the fingers
Xanthomata (yellow cholesterol deposits on the skin)
Looks for signs of cardiovascular disease:
Missing limbs or digits after previous amputations
Midline sternotomy scar (previous CABG)
A scar on the inner calf for saphenous vein harvesting (previous CABG)
Focal weakness suggestive of a previous stroke
The peripheral pulses may be weak on palpation:
Radial
Brachial
Carotid
Abdominal aorta
Femoral
Popliteal
Posterior tibial
Dorsalis pedis
You can use a hand-held Doppler to accurately assess the pulses when they are difficult to palpate.
Signs of arterial disease on inspection are:
Skin pallor
Cyanosis
Dependent rubor (a deep red colour when the limb is lower than the rest of the body)
Muscle wasting
Hair loss
Ulcers
Poor wound healing
Gangrene (breakdown of skin and a dark red/black change in colouration)
On examination, there may be:
Reduced skin temperature
Reduce sensation
Prolonged capillary refill time (more than 2 seconds)
Changes during Buerger’s test
Buerger’s test
Buerger’s test is used to assess for peripheral arterial disease in the leg. There are two parts to the test.
The first part involves the patient lying on their back (supine). Lift the patient’s legs to an angle of 45 degrees at the hip. Hold them there for 1-2 minutes, looking for pallor. Pallor indicates the arterial supply is not adequate to overcome gravity, suggesting peripheral arterial disease. Buerger’s angle refers to the angle at which the leg is pale due to inadequate blood supply. For example, a Buerger’s angle of 30 degrees means that the legs go pale when lifted to 30 degrees.
The second part involves sitting the patient up with their legs hanging over the side of the bed. Blood will flow back into the legs assisted by gravity. In a healthy patient, the legs will remain a normal pink colour. In a patient with peripheral arterial disease, they will go:
Blue initially, as the ischaemic tissue deoxygenates the blood
Dark red after a short time, due to vasodilation in response to the waste products of anaerobic respiration
The dark red colour is referred to as rubor.
Arterial leg ulcers
Arterial ulcers are caused by ischaemia secondary to an inadequate blood supply. Typically, arterial ulcers:
Are smaller than venous ulcers
Are deeper than venous ulcers
Have well defined borders
Have a “punched-out” appearance
Occur peripherally (e.g., on the toes)
Have reduced bleeding
Are painful
Venous leg ulcers
Venous ulcers are caused by impaired drainage and pooling of blood in the legs. Typically, venous ulcers:
Occur after a minor injury to the leg
Are larger than arterial ulcers
Are more superficial than arterial ulcers
Have irregular, gently sloping borders
Affect the gaiter area of the leg (from the mid-calf down to the ankle)
Are less painful than arterial ulcers
Occur with other signs of chronic venous insufficiency (e.g., haemosiderin staining and venous eczema)
Investigating peripheral arterial disease
Ankle-brachial pressure index (ABPI)
Duplex ultrasound – ultrasound that shows the speed and volume of blood flow
Angiography (CT or MRI) – using contrast to highlight the arterial circulation
Ankle-brachial pressure index
Ankle-brachial pressure index (ABPI) is the ratio of systolic blood pressure (SBP) in the ankle (around the lower calf) compared with the systolic blood pressure in the arm. These readings are taken manually using a Doppler probe. For example, an ankle SBP of 80 and an arm SBP of 100 gives a ratio of 0.8 (80/100).
Results:
0.9 – 1.3 is normal
0.6 – 0.9 indicates mild peripheral arterial disease
0.3 – 0.6 indicates moderate to severe peripheral arterial disease
Less than 0.3 indicates severe disease to critical ischaemic
An ABPI above 1.3 can indicate calcification of the arteries, making them difficult to compress. This is more common in diabetic patients.
Managing intermittent claudication
Lifestyle changes are required to manage modifiable risk factors (e.g., stop smoking). Optimise medical treatment of co-morbidities (such as hypertension and diabetes).
Exercise training, involving a structured and supervised program of regularly walking to the point of near-maximal claudication and pain, then resting and repeating.
Medical treatments:
Atorvastatin 80mg
Clopidogrel 75mg once daily (aspirin if clopidogrel is unsuitable)
Naftidrofuryl oxalate (5-HT2 receptor antagonist that acts as a peripheral vasodilator)
Surgical options:
Endovascular angioplasty and stenting
Endarterectomy – cutting the vessel open and removing the atheromatous plaque
Bypass surgery – using a graft to bypass the blockage
Endovascular angioplasty and stenting involve inserting a catheter through the arterial system under x-ray guidance. At the site of the stenosis, a balloon is inflated to create space in the lumen. A stent is inserted to keep the artery open. Endovascular treatments have lower risks but might not be suitable for more extensive disease.
Managing critical limb ischaemia
Patients with critical limb ischaemia require urgent referral to the vascular team. They require analgesia to manage the pain.
Urgent revascularisation can be achieved by:
Endovascular angioplasty and stenting
Endarterectomy
Bypass surgery
Amputation of the limb if it is not possible to restore the blood supply
Managing acute limb ischaemia
Patients with acute limb ischaemia need an urgent referral to the on-call vascular team for assessment.
Management options include:
Endovascular thrombolysis – inserting a catheter through the arterial system to apply thrombolysis directly into the clot
Endovascular thrombectomy – inserting a catheter through the arterial system and removing the thrombus by aspiration or mechanical devices
Surgical thrombectomy – cutting open the vessel and removing the thrombus
Endarterectomy
Bypass surgery
Amputation of the limb if it is not possible to restore the blood supply
Venous thromboembolism
Venous thromboembolism (VTE) is a common and potentially fatal condition. It involves blood clots (thrombi) developing in the circulation. This usually occurs secondary to stagnation of blood and hyper-coagulable states. When a thrombus develops in the venous circulation, it is called a deep vein thrombosis (DVT).
Once a thrombus has developed, it can travel (embolise) from the deep veins, through the right side of the heart and into the lungs, where it becomes lodged in the pulmonary arteries. This blocks blood flow to areas of the lungs and is called a pulmonary embolism (PE).
If the patient has a hole in their heart (for example, an atrial septal defect), the blood clot can pass through to the left side of the heart and into the systemic circulation. If it travels to the brain, it can cause a large stroke.
Risk factors of VTE
There are several factors that can put patients at higher risk of developing a DVT or PE. In many of these situations (e.g., surgery), we give patients prophylactic treatment to prevent VTE.
Immobility
Recent surgery
Long haul travel
Pregnancy
Hormone therapy with oestrogen (combined oral contraceptive pill and hormone replacement therapy)
Malignancy
Polycythaemia
Systemic lupus erythematosus
Thrombophilia
TOM TIP: In your exams, when a patient presents with possible features of a DVT or PE, ask about risk factors such as periods of immobility, surgery and long haul flights to score extra points.
Thrombophilias
Thrombophilias are conditions that predispose patients to develop blood clots. There are a large number of these:
Antiphospholipid syndrome
Factor V Leiden
Antithrombin deficiency
Protein C or S deficiency
Hyperhomocysteinaemia
Prothombin gene variant
Activated protein C resistance
TOM TIP: If you remember one cause of recurrent venous thromboembolism, remember antiphospholipid syndrome. The common association you may come across in exams is recurrent miscarriage. The diagnosis can be made with a blood test for antiphospholipid antibodies.
VTE prophylaxis
Every patient admitted to hospital should be assessed for their risk of venous thromboembolism (VTE). If they are at increased risk of VTE, they should receive prophylaxis unless contraindicated. Prophylaxis is usually with low molecular weight heparin, such as enoxaparin. Contraindications include active bleeding or existing anticoagulation with warfarin or a DOAC.
Anti-embolic compression stockings are also used, unless contraindicated. The main contraindication for compression stockings is significant peripheral arterial disease.
DVT presentation
DVTs are almost always unilateral. Bilateral DVT is rare and bilateral symptoms are more likely due to an alternative diagnosis such as chronic venous insufficiency or heart failure. DVTs can present with:
Calf or leg swelling
Dilated superficial veins
Tenderness to the calf (particularly over the site of the deep veins)
Oedema
Colour changes to the leg
To examine for leg swelling, measure the circumference of the calf 10cm below the tibial tuberosity. More than 3cm difference between calves is significant.
Always ask questions and examine with the suspicion of a potential pulmonary embolism as well.
Wells score
The Wells score predicts the risk of a patient presenting with symptoms having a DVT or PE. It includes risk factors such as recent surgery and clinical findings such as unilateral calf swelling 3cm greater than the other leg.
Diagnosing DVT
D-dimer is a sensitive (95%), but not specific, blood test for VTE. This makes it helpful in excluding VTE where there is a low suspicion. It is almost always raised if there is a DVT; however other conditions can also cause a raised d-dimer:
Pneumonia
Malignancy
Heart failure
Surgery
Pregnancy
Doppler ultrasound of the leg is required to diagnose deep vein thrombosis. NICE recommends repeating negative ultrasound scans after 6-8 days if a positive D-dimer and the Wells score suggest a DVT is likely.
Pulmonary embolism can be diagnosed with a CT pulmonary angiogram (CTPA) or ventilation-perfusion (VQ) scan. CTPA is usually preferred, unless the patient has significant kidney impairment or a contrast allergy.
Initial management of DVT
The initial management for a suspected or confirmed DVT or PE is with anticoagulation. In most patients, NICE (2020) recommend treatment dose apixaban or rivaroxaban. It should be started immediately in patients where DVT or PE is suspected, and there is a delay in getting the scan.
The NICE guidelines (2020) recommend considering catheter-directed thrombolysis in patients with a symptomatic iliofemoral DVT and symptoms lasting less than 14 days. This involves inserting a catheter under x-ray guidance through the venous system to apply thrombolysis directly into the clot.
Long term anticoagulation and VTE
The options for long term anticoagulation in VTE are a DOAC, warfarin, or LMWH.
DOACs are oral anticoagulants that do not require monitoring. They were called “novel oral anticoagulants” (NOACs), but this has been changed to “direct-acting oral anticoagulants” (DOACs). Options are apixaban, rivaroxaban, edoxaban and dabigatran. They are suitable for most patients, including patients with cancer.
Warfarin is a vitamin K antagonist. The target INR for warfarin is between 2 and 3 when treating DVTs and PEs. It is the first-line in patients with antiphospholipid syndrome (who also require initial concurrent treatment with LMWH).
Low molecular weight heparin (LMWH) is the first-line anticoagulant in pregnancy.
Continue anticoagulation for:
3 months if there is a reversible cause (then review)
Beyond 3 months if the cause is unclear, there is recurrent VTE, or there is an irreversible underlying cause such as thrombophilia (often 6 months in practice)
3-6 months in active cancer (then review)
Inferior vena cava filter
Inferior vena cava filters are devices inserted into the inferior vena cava, designed to filter the blood and catch any blood clots travelling from the venous system, towards the heart and lungs. They act as a sieve, allowing blood to flow through whilst stopping larger blood clots. They are used in unusual cases of patients with recurrent PEs or those that are unsuitable for anticoagulation.